Lewis Choi Appointed as Chief Information Officer & Senior Vice President at Neurocrine Biosciences — Leading the Next Frontier of AI-Driven Transformation in Life Sciences
Neurocrine Biosciences is proud to welcome Lewis Choi as its new Chief Information Officer and Senior Vice President, ushering in an era where technology, data, and AI converge to accelerate innovation in the service of human health. With a career spanning over two decades, Lewis is not just a technologist — he is a visionary architect of enterprise transformation, an AI trailblazer, and a leader who turns bold ideas into measurable, sustained business value.
A Track Record of Global Digital Impact
Lewis’ career has been defined by his ability to unite strategy, innovation, and execution at a scale few achieve. At Thermo Fisher Scientific, where he served for over 11 years, Lewis rose to become Vice President of AI Automation & Data, creating and leading a global function that brought together AI (including Generative AI), automation, and data capabilities under one cohesive strategy.
His leadership resulted in groundbreaking initiatives such as:
- Launching Gene.AI — a secure, self-funded generative AI platform adopted by 40% of employees within just 12 months, forecasted to deliver $1B in productivity savings over six years.
- Building specialized AI teams — including Generative AI Experience, AI System Training & Transformation (ASTAT), and an Accelerator Program that fast-tracked innovation.
- Establishing a Responsible AI framework that balanced rapid innovation with ethical, legal, and cybersecurity safeguards.
As Global VP of Digital Platforms, Engineering & Generative AI, he led a 1,200-member global team in a $40B enterprise, delivering self-service platforms that boosted customer engagement, cut document requests by 52%, and saved over $5M annually through cloud cost optimization.
Transforming Regions, Markets, and Revenue Growth
Lewis’ leadership extended far beyond North America. As VP, Digital | IT – APAC and Emerging Markets, he led 400+ professionals across China, Korea, India, Southeast Asia, Japan, and Latin America, achieving:
- A $115M sales pipeline through enhanced call center operations — exceeding targets by 30%.
- Over $500M in eCommerce sales in 2020.
- A digital automation Center of Excellence in APAC, delivering $3M in savings in its first year.
Earlier, as VP, IT – Digital Solutions China, he restructured teams for agility, drove 20% YoY online growth, and delivered $48M in sales pipeline via data-driven telesales programs.
Integration, M&A, and Enterprise Delivery Expertise
Lewis also played a pivotal role in high-value M&A integrations, including the $4.2B FEI and $1.2B Affymetrix acquisitions, creating playbooks still in use for large-scale post-merger digital integration. His oversight in web migrations, ERP consolidations, and platform integrations ensured seamless operational continuity.
From Entrepreneur to Enterprise Leader
Before his Thermo Fisher, tenure, Lewis co-founded SysGroup Incorporated, a boutique CRM consultancy serving biotech and tech sectors. Early roles with ADP, Corio Inc., and Serene Corporation honed his technical expertise and grounded him in the discipline of enterprise system architecture.
Charting Neurocrine’s Digital Future
At Neurocrine Biosciences , Lewis will lead enterprise IT strategy, digital transformation, AI integration, and data-driven decision-making. His leadership will be instrumental in advancing Neurocrine’s mission: to discover, develop, and deliver life-changing medicines.
With mastery in Generative AI, value stream mapping, IT-enabled transformation, and global operational leadership, Lewis is uniquely positioned to elevate Neurocrine’s digital capabilities, enhance agility, and empower teams to translate technology into tangible value — for the organization, its partners, and ultimately, for patients worldwide.
CXO Gateway Spotlight
This announcement is proudly featured by CXO Gateway, the premier platform dedicated to spotlighting exceptional leaders who are redefining industries, shaping corporate culture, and driving global impact. By showcasing Lewis Choi’s journey, CXO Gateway not only celebrates a career of transformative achievements but also inspires the next generation of leaders to embrace innovation, lead with integrity, and turn vision into action.
With mastery in Generative AI, value stream mapping, IT-enabled transformation, and global operational leadership, Lewis is uniquely positioned to elevate Neurocrine’s digital capabilities, enhance agility, and empower teams to translate technology into tangible value — for the organization, its partners, and ultimately, for patients worldwide.
Please join us in welcoming Lewis Choi — a leader whose vision and impact will help shape the future of healthcare innovation.